Taurine enhances antinociception produced by a COX-2 inhibitor in an inflammatory pain model

Inflammation

Volumn 36, Issue 3, 2013, Pages 658-664

  De Rienzo Madero, Beatriz ^a   Coffeen, Ulises ^a   Simón Arceo, Karina ^a   Mercado, Francisco ^a   Jaimes, Orlando ^a   Magis Weinberg, Lucía ^a   Contreras, Bernardo ^a   Pellicer, Francisco ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

celecoxib; COX 2 inhibitor; glycine A receptor; inflammation; pain; taurine

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; TAURINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHEMOSENSITIZATION; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENTIATION; ENZYME INHIBITION; INFLAMMATORY PAIN; LATENT PERIOD; LOW DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; MECHANONOCICEPTION; MONOTHERAPY; NOCICEPTION; NONHUMAN; RAT; THERMONOCICEPTION; TREATMENT RESPONSE; WITHDRAWAL REFLEX;

ANALGESICS; ANIMALS; CARRAGEENAN; CYCLOOXYGENASE 2 INHIBITORS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; INFLAMMATION; MALE; PAIN; PAIN MEASUREMENT; PYRAZOLES; RATS; RATS, WISTAR; SULFONAMIDES; TAURINE;

EID: 84877780971     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9589-4     Document Type: Article

References (27)

1. Sandkuhler, J. 1996. Neurobiology of spinal nociception: new concepts. Progress in Brain Research 110: 207-224.
2. Cervero, F., and J.M. Laird. 1996. From acute to chronic pain: mechanisms and hypotheses. Progress in Brain Research 110: 3-15.
3. Woolf, C.J., and M. Costigan. 1999. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proceedings of the National Academy of Sciences of the United States of America 96: 7723-7730.
4. Latremoliere, A., and C.J. Woolf. 2009. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. The Journal of Pain 10: 895-926.
5. Telleria-Diaz, A., M. Schmidt, S. Kreusch, A.K. Neubert, F. Schache, E. Vazquez, H. Vanegas, H.G. Schaible, and A. Ebersberger. 2010. Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids. Pain 148: 26-35.
6. Rezende, R.M., W.G. Dos Reis, I.D. Duarte, P.P. Lima, Y.S. Bakhle, and J.N. de Francischi. 2009. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids. Pain 142: 94-100.
7. Yan, L.H., J.F. Hou, M.G. Liu, M.M. Li, X.Y. Cui, Z.M. Lu, F.K. Zhang, Y.Y. An, L. Shi, and J. Chen. 2009. Imbalance between excitatory and inhibitory amino acids at spinal level is associated with maintenance of persistent pain-related behaviors. Pharmacological Research: The Official Journal of the Italian Pharmacological Society 59: 290-299.
8. Ye, G., A.C. Tse, and W. Yung. 1997. Taurine inhibits rat substantia nigra pars reticulata neurons by activation of GABA- and glycine-linked chloride conductance. Brain Research 749: 175-179.
9. Chattipakorn, S.C., and L.L. McMahon. 2003. Strychnine-sensitive glycine receptors depress hyperexcitability in rat dentate gyrus. Journal of Neurophysiology 89: 1339-1342.
10. Mori, M., B.H. Gahwiler, and U. Gerber. 2002. Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. The Journal of Physiology 539: 191-200.
11. Jiang, Z., K. Krnjevic, F. Wang, and J.H. Ye. 2004. Taurine activates strychnine-sensitive glycine receptors in neurons freshly isolated from nucleus accumbens of young rats. Journal of Neurophysiology 91: 248-257.
12. Lim, E.S., and I.O. Lee. 2010. Effect of intrathecal glycine and related amino acids on the allodynia and hyperalgesic action of strychnine or bicuculline in mice. Korean Journal of Anesthesiology 58: 76-86.
13. Belfer, I., E. Davidson, A. Ratner, E. Beery, Y. Shir, and Z. Seltzer. 1998. Dietary supplementation with the inhibitory amino acid taurine suppresses autotomy in HA rats. Neuroreport 9: 3103-3107.
14. Serrano, J.S., M.I. Serrano, M.R. Guerrero, R. Ruiz, and J. Polo. 1990. Antinociceptive effect of taurine and its inhibition by naxolone. General Pharmacology 21: 333-336.
15. Pellicer, F., A. Lopez-Avila, U. Coffeen, J. Manuel Ortega-Legaspi, and R.D. Angel. 2007. Taurine in the anterior cingulate cortex diminishes neuropathic nociception: a possible interaction with the glycine(A) receptor. European Journal of Pain 11: 444-451.
16. Zimmermann, M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
17. Lopez-Avila, A., G. Rodriguez-Manzo, U. Coffeen, R. del Angel, and F. Pellicer. 2004. Self-injury behaviour induced by intraplantar carrageenan infiltration: a model of tonic nociception. Brain Research. Brain Research Protocols 13: 37-44.
18. Werner, U., D. Werner, A. Pahl, R. Mundkowski, M. Gillich, and K. Brune. 2002. Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry. Biomedical Chromatography: BMC 16: 56-60.
19. Ghandforoush-Sattari, M., S. Mashayekhi, C.V. Krishna, J.P. Thompson, and P.A. Routledge. 2010. Pharmacokinetics of oral taurine in healthy volunteers. Journal of Amino Acids 2010: 346237.
20. Paulson, S.K., J.Y. Zhang, S.M. Jessen, Y. Lawal, N.W. Liu, C.M. Dudkowski, Y.F. Wang, M. Chang, D. Yang, J.W. Findlay, M.A. Berge, C.S. Markos, A.P. Breau, J.D. Hribar, and J. Yuan. 2000. Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey. Xenobiotica; The Fate of Foreign Compounds in Biological Systems 30: 731-744.
21. Ishikawa, T., M. Marsala, T. Sakabe, and T.L. Yaksh. 2000. Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist. Neuroscience 95: 781-786.
22. Legendre, P. 2001. The glycinergic inhibitory synapse. Cellular and Molecular Life Sciences: CMLS 58: 760-793.
23. Hara, K., M. Nakamura, Y. Haranishi, T. Terada, K. Kataoka, and T. Sata. 2012. Antinociceptive effect of intrathecal administration of hypotaurine in rat models of inflammatory and neuropathic pain. Amino Acids 43: 397-404.
24. Shin, M.C., M.H. Jang, H.K. Chang, Y.J. Kim, E.H. Kim, and C.J. Kim. 2003. Modulation of cyclooxygenase-2 on glycine- and glutamate-induced ion currents in rat periaqueductal gray neurons. Brain Research Bulletin 59: 251-256.
25. Marcinkiewicz, J. and E. Kontny. 2012. Taurine and inflammatory diseases. Amino Acids (in press).
26. Savage, R. 2005. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly? Drugs & Aging 22: 185-200.
27. Risser, A., D. Donovan, J. Heintzman, and T. Page. 2009. NSAID prescribing precautions. American Family Physician 80: 1371-1378.